In this webinar, Ergomed’s experts Alex Artyomenko, Christa van Kan and Sally Amanuel shared their insights on how Ergomed has adapted and is continuing to provide reliable and uninterrupted services for clients during the COVID-19 crisis, keeping the patient’s safety and well-being as the central focus.

00:00 – Introduction
00:41 – Ensuring Oversight of Ongoing Trials
03:00 – Risk Assessment
05:47 – Remote and Centralized Monitoring
10:47 – Handling Missing Data
12:18 – Practical and Logistical Issues and Mitigations
13:11 – Travel Restrictions & Hospital Lockdowns
17:09 – Delays in Shipment of IMP/SAMPLES/SUPPLIES
19:35 – Drop-in Recruitment
21:16 – Limited Availability of Site Staff
22:13 – Starting Up New Trials During the COVID-19 Pandemic
22:36 – Evolving Regulatory Environment
24:31 – Supplement Your CTA Dossier
27:54 – Key Steps When Planning to Conduct Clinical Trial During COVID-19 Pandemic
31:16 – Case Study: Ergomed COVID-19 Study in Northern Italy
31:52 – SISCO Study: Siltuximab in Serious COVID-19
34:55 – Questions and answers

свернуть